ArticleJournal of translational medicine2023

Tamoxifen exerts anti-peritoneal fibrosis effects by inhibiting H19-activated VEGFA transcription.

Tingting Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.